Cargando…
Thromboembolism and bleeding in systemic amyloidosis: a review
The assessment of both thromboembolic and haemorrhagic risks and their management in systemic amyloidosis have been poorly emphasized so far. This narrative review summarizes main evidence from literature with clinical perspective. The rate of thromboembolic events is as high as 5–10% amyloidosis pa...
Autores principales: | Nicol, Martin, Siguret, Virginie, Vergaro, Giuseppe, Aimo, Alberto, Emdin, Michele, Dillinger, Jean Guillaume, Baudet, Mathilde, Cohen‐Solal, Alain, Villesuzanne, Camille, Harel, Stephanie, Royer, Bruno, Arnulf, Bertrand, Logeart, Damien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787981/ https://www.ncbi.nlm.nih.gov/pubmed/34784656 http://dx.doi.org/10.1002/ehf2.13701 |
Ejemplares similares
-
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
por: Nicol, Martin, et al.
Publicado: (2023) -
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2020) -
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis
por: Emdin, Michele, et al.
Publicado: (2023) -
High body mass index is a predictor of left ventricular reverse remodelling in heart failure with reduced ejection fraction
por: Cescau, Arthur, et al.
Publicado: (2017) -
Delayed acute myocarditis and COVID‐19‐related multisystem inflammatory syndrome
por: Nicol, Martin, et al.
Publicado: (2020)